Dramatic improvement after tocilizumab of severe COVID ‐19 in a child with sickle cell disease and acute chest syndrome

REFERENCES 1. Thomas-Ruddel D, Winning J, Dickmann P, et al. Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020. Anaesthesist. 2020;69(4):225-235. 2. Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle region case series. N Engl J Med. 2020;382: 2012-2022. 3. Levi MT, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438-e440. 4. Azkur AK, Akdis M, Azkur D, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020. https://doi.org/10.1111/all.14364. Online ahead of print. 5. Goeijenbier M, van Wissen M, van de Weg C, et al. Review: viral infections and mechanisms of thrombosis and bleeding. J Med Virol. 2012; 84(10):1680-1696. 6. Lazarian G, Quinquenel A, Bellal M, et al. Autoimmune hemolytic anemia associated with Covid-19 infection. Br J Haematol. 2020. https:// doi.org/10.1111/bjh.16794. Online ahead of print. 7. Zulfiqar AA, Lorenzo-Villalba N, Hassler P, Andres E. Immune thrombocytopenic purpura in a patient with Covid-19. N Engl J Med. 2020;382(18):e43.